NASDAQ
Benitec Biopharma Inc. (BNTC) has a current ratio of 54.67x as of Tuesday, May 26, 2026. This represents a 670.33% increase compared to its 12-month average of 7.10x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.